Hormone-dependent regulation of BRCA1 in human breast cancer cells.

BRCA1 mRNA and protein levels are regulated by the steroid hormones estrogen and progesterone in human breast cancer cells. BRCA1 mRNA and protein levels were significantly decreased in estrogen-depleted MCF-7 and BT20T cells and increased again after stimulation with beta-estradiol. The increase in BRCA1 expression upon stimulation with estrogen was not coordinated with the early induction of the estrogen-dependent pS2 gene but closely paralleled the delayed increase in the S-phase dependent marker cyclin A. T47-D cells deprived of steroid hormones and subsequently stimulated with progesterone also showed a delayed increase in BRCA1 mRNA expression. However, no change in BRCA1 protein was detected in these cells. When considered together, the data suggest that steroid hormones may affect BRCA1 expression indirectly by altering the proliferative status of the cells rather than acting directly on DNA sequences in the BRCA1 gene itself.

[1]  R. Guzman,et al.  Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Kenneth H. Cowan,et al.  Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[4]  C. Sherr.  G1 phase progression: Cycling on cue , 1994, Cell.

[5]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[6]  E. Kalkhoven,et al.  Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor , 1994, Molecular and Cellular Endocrinology.

[7]  J. A. Hamilton,et al.  Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. , 1993, Molecular and cellular biology.

[8]  E Marshall,et al.  Epidemiology. Search for a killer: focus shifts from fat to hormones , 1993, Science.

[9]  J. Laborda,et al.  36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. , 1991, Nucleic acids research.

[10]  P Chambon,et al.  The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c‐Ha‐ras oncoprotein and the c‐jun protein. , 1989, The EMBO journal.

[11]  P. Chambon,et al.  Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Chambon,et al.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. , 1982, Nucleic acids research.

[13]  M. Hentze,et al.  Translational regulation: versatile mechanisms for metabolic and developmental control. , 1995, Current opinion in cell biology.

[14]  F. Collins,et al.  Somatic mutations in the BRCA1 gene in sporadic ovarian tumours , 1995, Nature Genetics.

[15]  R. Clarke,et al.  Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions. , 1992, Critical reviews in oncology/hematology.